PDCD1 and non-small cell lung carcinoma: In this equation, (p = Responder) is the predicted probability of NSCLC patients benefiting from PD-1 blockade therapy, (Hyp) and (His) are the serum concentrations of hypoxanthine and histidine, respectively, at early on-treatment.